SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-21-024168
Filing Date
2021-02-16
Accepted
2021-02-16 16:33:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm216840d12_sc13g.htm SC 13G/A 46543
  Complete submission text file 0001104659-21-024168.txt   47999
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Subject) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89674 | Film No.: 21639397
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3 EAST 28TH STREET, 7TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET, 7TH FLOOR NEW YORK NY 10016 212-426-7040
ARK Investment Management LLC (Filed by) CIK: 0001697748 (see all company filings)

IRS No.: 464309299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A